Sensei Biotherapeutics, Inc. (SNSE)
About Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics Inc is a clinical-stage biotechnology company engaged in the development of therapies targeting cancer through multi-node inhibition of oncogenic pathways. The company's lead program, PIKTOR, is an investigational oral combination therapy designed to inhibit multiple nodes of the PI3K/AKT/mTOR pathway and is being evaluated for the treatment of endometrial and breast cancers. In addition, the company is advancing other pipeline programs targeting tumor metabolism and signaling pathways.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$21.1M
- Total assets
- $22.9M
- Market cap
- $19.7M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $22.3M
- Operating income
- -$22.3M
- Income tax
- -$2.6M
- Net income
- -$21.1M
- EPS (basic)
- $-16.72
- EPS (diluted)
- $-16.72
Balance sheet
- Total assets
- $22.9M
- Current assets
- $21.5M
- Total liabilities
- $4.3M
- Current liabilities
- $4.3M
- Shareholders’ equity
- $18.6M
Cash flow
- Operating cash flow
- -$20.5M
- Investing cash flow
- $19.8M
- Financing cash flow
- -$645.0K
- Net cash flow
- -$1.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $19.7M
- EPS (diluted)
- $-16.72
- Shares outstanding
- 1.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 4, 2021
Sensei Biotherapeutics, Inc. (SNSE) Stock Price
- Reported a net loss of $21.1M.
- Trading 61% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Sensei Biotherapeutics, Inc..
Write a review
News about Sensei Biotherapeutics, Inc.
News & sentiment via Polygon.io
Sensei Biotherapeutics, Inc.: frequently asked questions
Is Sensei Biotherapeutics, Inc. an American company?
Sensei Biotherapeutics, Inc. is a US-based company headquartered in Rockville, Maryland, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Sensei Biotherapeutics, Inc. headquartered?
Sensei Biotherapeutics, Inc. is headquartered in Rockville, Maryland, United States.
Is Sensei Biotherapeutics, Inc. publicly traded?
Yes — Sensei Biotherapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol SNSE on the NASDAQ.
What does Sensei Biotherapeutics, Inc. do?
Sensei Biotherapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
